A little exert from Co Prospectus IPO2 Mar 2021 14:25
‘The Company is initially focusing on two product lines, the first being high-end skincare, and the second being athletic recovery products. The Company’s high-end skincare products have been developed with Arcania Apothecary, and have been developed with a key set of core values, being: efficacy, stability and ecology. The Company’s athletic recovery products have been developed to aid sportspeople in their post-exercise and post- event recovery.
The Company is launching with two product brands covering distinct market segments: a high-quality face-mask and serum containing synthetic CBD, and a topical athletic recovery gel roll-on product. The Company considers that synthetic CBD is the most consistent, ecologically sensitive, scalable, and compliant source of CBD available. The products have been developed by Arcania Apothecary while the synthetic CBD is sourced from pharmaceutical grade suppliers and incorporated into the cream by Arcania Apothecary, the Company’s established apothecary contract manufacturing organisation (CMO). In so doing, the Company will have visibility and control over the entire production process, and be able to ensure consistency in the quality and content of its products. This internal quality control will be verified by batch testing of the final product by independent laboratories, the results of which will be available to the consumer. The Company considers that direct-to-consumer sales and marketing provide the Company with direct and timely feedback and customer engagement that is simply unavailable through conventional distribution channels, while the retail partnership provides an additional route to market and greater exposure for the Company’s products. The Company believes this hybrid approach will significantly expedite the creation and focusing of the Company’s initial product and future product range, identification of consumer trends and preferences, and potential for product personalisation on an ongoing basis.‘
‘The company is LAUNCHING WITH TWO PRODUCT BRANDS’ - all those trying to mislead people by claiming they have nothing yet are nugget munching clowns.
We could hear news of big media frenzy (I’m sure with DB on board) product launch, global tie ins, global deals, sponsorship deals, affiliation deals etc etc etc etc at any time. Do you think they started this co with fresh air - lol
Have products will sell. I suggest we all HOLD and don’t SELL simply to fund others investors purchases cheaper.
CBD is the next trend - you’re all lucky you found this now at peanut level entry while those like Peter Wall et al concentrate on making this a global first mover advantage brand on LSE...then no doubt US markets next.
IMHO DYOR GLA